Skip to main content
. Author manuscript; available in PMC: 2019 May 14.
Published in final edited form as: Cancer Cell. 2018 May 14;33(5):905–921.e5. doi: 10.1016/j.ccell.2018.04.002

Figure 2.

Figure 2.

High influx of glucose and glutamine in lung SCC detected by PET imaging.

(A) Representative PET and CT images of SCC tumors from KL mice imaged with 18F-FDG and 11C-Glutamine. (B) Image of whole lungs and heart from mouse imaged in (A). Tumor is circled. T = tumor. H = heart. (C) Left lung lobe and tumor from mouse imaged in (A) stained for hematoxylin and eosin (H&E). Magnified image shown in the inset; scale bar = 25 μm. (D) Serial sections of the left lung lobe stained with CK5/TTF1, GLUT1, SLC1A5 from left lobe from mouse imaged in (A). Magnified images shown in the inset; scale bar = 25 μm. (E) PET/CT images of KL mouse with both ADC and SCC tumors imaged with CT (left), 18F-FDG (middle), and 11C-Glutamine (right). H = heart, L = liver. T1 and T2 are outlined with dashed lines (T1 = the blue line, T2 = the red line). (F) PET/CT imaged ADC and SCC lung tumors from (E) were stained with antibodies against CK5/TTF1, GLUT1 and SLC1A5 (left side). Scale bar = 1 mm. Magnified images from T1 (blue box) and T2 (red box) are shown on the right side. Scale bar = 50 μm. See also Figure S2.

HHS Vulnerability Disclosure